Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuri Klyachkin

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Virology|October 25, 2013
Mutations in the amino terminus of herpes simplex virus type 1 gL can reduce cell-cell fusion without affecting gH/gL traffickingWenbo Zhou, Feng Chen, Yuri Klyachkin, et al.
JAAD International|July 29, 2024
Diabetes and obesity burden and improvements in cardiometabolic parameters in patients with psoriasis or psoriatic arthritis receiving apremilast in a real-world settingCristi Cavanaugh, Kate Orroth, Xi Qian, et al.
Open Access Rheumatology : Research and Reviews|June 23, 2022
Biologic Initiation Rate in Systemic-Naïve Psoriatic Arthritis Patients Starting Treatment with Apremilast vs Methotrexate: 1-Year Retrospective Analysis of a US Claims DatabaseM Elaine Husni, Eunice Chang, Michael S Broder, et al.
Dermatology and Therapy|May 14, 2023
Patient and Physician Perceptions of Psoriatic Disease in the United States: Results from the UPLIFT SurveyJoseph F Merola, Alexis Ogdie, Alice B Gottlieb, et al.
Dermatology and Therapy|April 4, 2026
Envudeucitinib, a Potent, Next-Generation, Allosteric Inhibitor of TYK2: A Narrative ReviewApril W Armstrong, James G Krueger, Bruce E Strober, et al.
Stem Cells Translational Medicine|March 16, 2017
Bioactive Lipids and Circulating Progenitor Cells in Patients with Cardiovascular DiseaseSalim S Hayek, Yuri Klyachkin, Ahmed Asfour, et al.
The Lancet. Rheumatology|November 2, 2024
Effect of apremilast on hand and whole-body MRI assessments of inflammation in patients with psoriatic arthritis (MOSAIC): a phase 4, multicentre, single-arm, open-label studyMikkel Østergaard, Mikael Boesen, Walter P Maksymowych, et al.
Annals of the Rheumatic Diseases|August 20, 2024
Treatment of early oligoarticular psoriatic arthritis with apremilast: primary outcomes at week 16 from the FOREMOST randomised controlled trialLaure Gossec, Laura C Coates, Dafna D Gladman, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Virology|October 25, 2013
Mutations in the amino terminus of herpes simplex virus type 1 gL can reduce cell-cell fusion without affecting gH/gL traffickingWenbo Zhou, Feng Chen, Yuri Klyachkin, et al.
JAAD International|July 29, 2024
Diabetes and obesity burden and improvements in cardiometabolic parameters in patients with psoriasis or psoriatic arthritis receiving apremilast in a real-world settingCristi Cavanaugh, Kate Orroth, Xi Qian, et al.
Open Access Rheumatology : Research and Reviews|June 23, 2022
Biologic Initiation Rate in Systemic-Naïve Psoriatic Arthritis Patients Starting Treatment with Apremilast vs Methotrexate: 1-Year Retrospective Analysis of a US Claims DatabaseM Elaine Husni, Eunice Chang, Michael S Broder, et al.
Dermatology and Therapy|May 14, 2023
Patient and Physician Perceptions of Psoriatic Disease in the United States: Results from the UPLIFT SurveyJoseph F Merola, Alexis Ogdie, Alice B Gottlieb, et al.
Dermatology and Therapy|April 4, 2026
Envudeucitinib, a Potent, Next-Generation, Allosteric Inhibitor of TYK2: A Narrative ReviewApril W Armstrong, James G Krueger, Bruce E Strober, et al.
Stem Cells Translational Medicine|March 16, 2017
Bioactive Lipids and Circulating Progenitor Cells in Patients with Cardiovascular DiseaseSalim S Hayek, Yuri Klyachkin, Ahmed Asfour, et al.
The Lancet. Rheumatology|November 2, 2024
Effect of apremilast on hand and whole-body MRI assessments of inflammation in patients with psoriatic arthritis (MOSAIC): a phase 4, multicentre, single-arm, open-label studyMikkel Østergaard, Mikael Boesen, Walter P Maksymowych, et al.
Annals of the Rheumatic Diseases|August 20, 2024
Treatment of early oligoarticular psoriatic arthritis with apremilast: primary outcomes at week 16 from the FOREMOST randomised controlled trialLaure Gossec, Laura C Coates, Dafna D Gladman, et al.
Pageof 1